Epigenetics of Alzheimer’s Disease

There are currently no validated biomarkers which can be used to accurately diagnose Alzheimer’s disease (AD) or to distinguish it from other dementia-causing neuropathologies. Moreover, to date, only symptomatic treatments exist for this progressive neurodegenerative disorder. In the search for new...

Descripción completa

Detalles Bibliográficos
Autores principales: Nikolac Perkovic, Matea, Videtic Paska, Alja, Konjevod, Marcela, Kouter, Katarina, Svob Strac, Dubravka, Nedic Erjavec, Gordana, Pivac, Nela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7911414/
https://www.ncbi.nlm.nih.gov/pubmed/33573255
http://dx.doi.org/10.3390/biom11020195

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7911414/
https://www.ncbi.nlm.nih.gov/pubmed/33573255
http://dx.doi.org/10.3390/biom11020195

Ejemplares similares